GTR 66221385
Tenders Are Invited For 23/46 Anticancer Drug (Pertuzumab/Trastuzumab)
ICB — International Competitive Bid
Closed
Eastern Europe
Tender Information
GTR Reference
66221385
Tendering Authority
Subscribe to view
Tender No
2211712
Financer Name
Self-Funded
Work Title
Tenders Are Invited For 23/46 Anticancer Drug (Pertuzumab/Trastuzumab)
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
Eastern Europe
Political Region
Commonwealth of Independent States CIS
Last Date of Bid Submission
04-07-2023
Closed
Work Detail
23/46 Anticancer Drug (Pertuzumab/Trastuzumab).Drug Pertuzumab/Trastuzumab Subcutaneous Solution 600 Mg/600 Mg
Key Value
Tender Value
12,877,316 - BYN
Tender Documents
Global Tender Document
0dd02128-4c7c-4357-91f7-877f9c1d8bd2.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.